6901- Study of SCID Disorders

Official Title

RDCRN PIDTC Protocol #6901, A Prospective Natural History Study of Diagnosis, Treatment and Outcomes of Children with SCID Disorders

Study Details

The goal of the study is to learn more about treatment outcomes of patients with immune deficiency disorders.

Principal Investigator

Dr. Jeffrey Bednarski

IRB Number



Participants must have Primary Immune Deficiency (PID) including: severe combined immunodeficiency (SCID), Omenn syndrome (OS), and Reticular Dysgenesis (RD).

Volunteer Information

For more information about this study, contact Volunteer for Health at: